 |
| Small Scale Bioreactors Market |
The global Small Scale Bioreactors Market is estimated to be valued at US$ 1508.86 Mn in 2023 and is expected to exhibit a CAGR of 10.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Small scale bioreactors are used during research and development for
cultivating biological cells and tissues in controlled environmental
conditions. They are used to cultivate microorganisms and cell cultures for
clinical and research applications as they reduce production costs and have
high productivity.
Market key trends:
Advancements in cell culture technology: Cell culture technology has witnessed
tremendous innovations over the past few years. 3D cell culture techniques help
in cultivating cells in an environment that closely mimics natural tissues.
This has increased the demand for advanced small scale bioreactors that can support
3D cell cultures. Continuous cell line technologies also reduce development
timelines and increase productivity.
Increasing Focus on Continuous Processing: Continuous bioprocessing provides
significant advantages over traditional batch processes such as consistent
product quality, reduced contaminations, higher yields and flexibility of
production. Many biopharmaceutical companies are replacing batch systems with
miniature bioreactors with integrated continuous downstream processing units to
achieve these benefits at small scale operations as well. This is expected to
significantly drive the demand for small scale bioreactors during the forecast
period.
Segment Analysis
The small scale bioreactors market is segmented into glass/single use, stainless
steel/perfusion, and multiple use bioreactors. The glass/single use bioreactors
segment held the largest market share in 2022 owing to its widespread use in
smaller volumes of reactions such as drug discovery and antibody production.
These are disposable, require minimal maintenance and validation efforts making
them suitable for rapid screening and process development.
Key Takeaways
The global Small
Scale Bioreactors Market Growth is expected to witness high growth,
exhibiting a CAGR of 10.% over the
forecast period, due to increasing demand for hybrid bioreactors and focus on
continuous bioprocesses.
Regional analysis
North America dominated the global market in 2022 and is expected to continue
its dominance over the forecast period. This is attributed to strong presence
of key players and growing trend of outsourcing manufacturing processes by
large pharmaceutical companies in the region. Asia Pacific is expected to be
the fastest growing market owing to increasing investments in bioprocessing
industry and growing volumes of biosimilars and biologics production in
countries like China and India.
Key players
Key players operating in the small scale bioreactors market are Merck KGaA
,Danaher Corporation, Getinge AB, Sartorius AG ,Thermo Fisher Scientific Inc. ,
Lonza Group , Eppendorf AG , Miltenyi Biotec, Solaris Biotechnology Srl, Infors
AG, Biosan, MicroDigital Co. Ltd., 2mag AG, MDX Biotechnik International GmbH,
Esco Lifesciences Group, HiTec Zang GmbH, Hanil Scientific Inc., Adolf Kü, hner
AG, Ori Biotech , Aglaris and AdvaBio. These companies are focusing on
developing single use bioreactors with advanced features to cater to emerging
demand for hybrid bioreactors from biopharma companies.
Read More,
0 Comments